The Hôpital du Sacré-Cœur de Montréal is a hospital in the Cartierville neighbourhood of Montreal, Quebec, Canada, bordering on Saint-Laurent. It is one of the largest teaching hospitals affiliated with the Université de Montréal, and one of the largest hospitals in Quebec.

There are 554 beds in CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal.

During the past decade, CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal" are "Lung Cancer" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal" in a lesser frequency.

Most popular intervention types in "CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dexamethasone" (1 trials), "Elotuzumab" (1 trials), "Epacadostat" (1 trials), "Nivolumab" (1 trials) and "Pembrolizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CIUSSS du Nord-de-l'ILe-de-Montreal Hopital du Sacre-Coeur de Montreal, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".